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Fibromyalgia (FM) is a chronic disorder characterized by widespread musculoskeletal
pain, fatigue, and/or multiple tender points located on the neck, shoulders, back, hips,
arms or legs that hurt when touched. FM can be a debilitating condition with financial,
emotional, interpersonal, and health costs that can affect not only the person diagnosed,
but his or her family and friends. Presently, the etiology of FM is largely unknown and
there is no definitive cure. Researchers have identified several possible contributing
factors in the development and maintenance of FM, including genetics, abnormalities in
the neuroendocrine system, and sleep disturbances as well as psychiatric disorders.
Victimization experiences (e.g., sexual and physical abuse) have also been cited in the
literature as a contributing factor. Prevalence rates for physical abuse and sexual abuse in
clinical samples range from 18% to 47.2% and 9.5% to 66.7%, respectively. However,
results obtained from studies using community representative samples have not been
consistent. Possible explanations for the discrepancy are discussed. Additionally, the
interplay between mental health and victimization experiences in FM are discussed using
McEwen’s (1998) allostatic load hypothesis and Van Houdenhove & Egle’s (2004)
biopsychosocial model of stress and FM.
vn
Introduction
Fibromyalgia (FM) is a chronic disorder characterized by widespread
musculoskeletal pain, fatigue, and/or multiple tender points located on the neck,
shoulders, back, hips, arms or legs that hurt when touched (National Institute of Arthritis
and Musculoskeletal and Skin Diseases [NIAMS], 2004). Recent estimates suggest that
FM affects 2 to 4 percent of the population, predominantly women (Clauw & Taylor-
Moon, 2006). As a whole, FM costs the US between $12-14 billion each year and
accounts for a loss of 1-2 percent of the nation’s overall productivity (Robinson et ah,
2003). Although the financial costs of FM are high, the personal costs of FM can be
staggering. The loss of support by friends and family because of fatigue has been
observed in patients with FM (Assefi et al., 2003). In addition, 50-70% of patients with
FM have reported experiencing major depression in their lifetime (Goldenberg, 1999;
Hudson et al., 1992). Recent estimates have also suggested a high prevalence of current
anxiety disorders, ranging from 32.3% to 63.8% in patients with FM (Martinez et al.,
1995; Theime et al., 2004).
A potential contributing factor in the development of FM is a history of
victimization experiences. Prevalence rates of physical and sexual abuse in patients with
FM range from 18% to 47.2% and 9.5% to 66.7%, respectively (Boisset-Pioro et al.,
1995; Boyd & Katsaros, 2006; Goldberg et al., 1999; Imbierowicz & Egle, 2002; Me
Beth et al. 1999; Rubin, 2005; Taylor et al., 1995; Van Houdenhove et al, 2001; Walker
et al., 1997). These relationships have led some researchers to suggest that victimization
experiences play a role in the development of FM (Aaron et al., 1997; Clauw & Williams,
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2002; Van Houdenhove, 2003). Sexually abused FM patients have reported higher levels
of physical symptoms (e.g., weakness and weight changes) and emotional symptoms
(e.g., feelings of depression) than non-sexually abused FM patients (Taylor et al, 1995).
Physically/sexually abused FM patients have also shown to report greater levels of pain,
fatigue, disability and lower levels of self-efficacy, a cognitive-related variable when
compared to non abused FM patients (Alexander et ah, 1998). Additionally, self-reported
emotional trauma in FM patients has shown increased levels of physical impairment in
actives including washing dishes, walking several blocks, etc. in comparison to FM non
patients who do report trauma exposure (Aaron et al., 1997).
Alternatively, researchers have argued that the high prevalence of victimization
experiences observed in patients with FM maybe largely due to the arbitrary and
unstructured nature of convenience sampling procedures, i.e., recruiting patients from
tertiary care clinics or primary care providers as opposed to community sampling
procedures (Ciccone et al., 2005; Thieme et al., 2004; Walker et al., 1997; White et al.,
2002). Others have also suggested that the high prevalence of physical and sexual abuse
histories observed in patients with FM is a reflection of treatment seeking behavior rather
than in the etiology of FM (Aaron et al., 1997; Alexander et al., 1998; Ciccone et al.,
2005).
The aim of the present paper is to evaluate mental health in FM and investigate
the relationship between FM and victimization experiences. In addition, the current
paper will help explain the interplay between mental health, victimization experiences,
and FM from McEwen’s (1998) allostatic load hypothesis and Van Houdenhove and
Egle’s (2004) biopsychosocial model of stress and FM.
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Causes and Treatment of FM
Unfortunately, the etiology of FM is largely unknown and there is no definitive
cure (NIAMS, 2004; Lind et ah, 2007). Researchers have pointed to genetics as playing
a key role in the development of FM (Arnold et al, 2004). In addition, a number of
abnormalities in the neuroendocrine system have been indentified, including the
hypothalamic-pituitary-adrenal axis, alterations in substance P levels, and low levels of
cortisol, growth hormones, norepinephrine, and serotonin (Clauw & Crofford, 2003).
Sleep disturbances are also suspected to contribute to the development and maintenance
of FM (Arthritis Research Campaign, 2004; Hamilton, Karlson, & Catley, 2007). As a
result, the etiology of FM appears multi-faceted and reflects a variety of disciplines,
including genetics, physiology, rheumatology, and sleep research.
However, not everyone in the medical community recognizes fibromyalgia as a
legitimate disease. Unlike other inflammatory diseases, many have remained skeptical
because there are currently no biological tests to diagnose fibromyalgia. Additionally, a
direct link to either biological or environmental factors has not been identified (Berenson,
2008). The unknown nature of FM in terms of etiology and treatment has been found to
further contribute to distress in those affected by FM (Johnson, Zautra, & Davis, 2006).
Because a consensus has not been reached regarding the etiology of FM,
treatment is focused on symptom management as opposed to curing the illness.
Currently, Lyrica (pregabalin), an antiepileptic drug, is the only pharmacological
treatment approved by the Food and Drug Administration in the treatment of FM (FDA
News, 2007). Antidepressants such as tricyclic antidepressants (e.g., amitriptyline) and
selective serotonin reuptake inhibitors (e.g., fluoxetine/Prozac) have also shown to reduce
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symptoms related to FM such as anxiety, depression, and fatigue (Peterson, 2007). There
is also a vast array of non pharmacologic therapies including exercise, psychoeducation
about FM, and cognitive behavioral therapy that have shown moderate effectiveness.
Other nonphannacologic therapies such as acupuncture, hypnotherapy, bio feedback,
relaxation therapy, baleneotherapy, chiropractic manipulation, massage, ultrasound, and
tender point injections are beginning to be sought out by individuals with FM; however,
more research is needed to determine their effectiveness (Peterson, 2007). Regardless of
whether an individual with FM chooses a pharmacological or nonpharmacological
treatment (or a combination of both); the regimen will target symptoms of FM.
Consequently, individuals with FM are faced with the frustrating reality that the research
community has not been able identify a known etiology or cure for their condition.
FM and Mental Health
According to Hudson & Pope (1989), FM is an affective spectrum disorder
because it shares similar pathophysiology with thirteen other psychiatric and medical
disorders. Psychiatric conditions considered within the affective spectrum include
posttraumatic stress disorder, attention-deficit/hyperactivity disorder, bulimia nervosa,
dysthymic disorder, generalized anxiety disorder, major depressive disorder, obsessive
compulsive disorder, panic disorder, premenstrual dysphoric disorder, and social phobia
(Hudson et ah, 2004). Other medical conditions in addition to FM considered within the
affect spectrum include irritable bowel syndrome, migraine, and cataplexy (Hudson et ah,
2004). One of the primary reasons these conditions have been grouped together within
the affective spectrum is because they commonly co-occur and tend to respond positively
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to anti-depressants (Okifuji & Turk, 1999). However, empirical evidence investigating
the affective spectrum model in patients with FM has been inconsistent (Aaron et ah,
1996; Kirmayer et ah, 1988; Okifuji & Turk, 1999). Inconsistencies observed may be
due to differences in data collection strategies (e.g., structured interview versus
standardized questionnaires) and sampling procedures (e.g., convenience sampling versus
community based sampling). Sample characteristics (e.g., patients with FM versus non­
patients with FM and including men in sample) as well as country of origin of study (e.g.,
Israel, Brazil, Germany, US, etc) may help explain inconsistencies. Additionally,
statistical sophistication may contribute to inconsistency between studies, e.g., choosing
whether or not to control for the effects of certain variables, such as demographics, pain
severity, or neuroticism on mental health functioning.
A variety of strategies and methodologies have been used by researchers to
investigate mental health issues in patients and individuals with FM. In the present
paper, “patient” refers to a subject drawn from a primary and/or tertiary clinic setting. A
tertiary clinic refers to a specific sub specialty of care, e.g., Rheumatology, which is
typically associated with a general hospital. When the word “individual” is used, it is in
reference to a study that used a representative community sample. A FM nonpatient
refers to an individual with muscular aches and pains who has not sought medical
treatment for their symptoms in the past ten years. These individuals are typically
recruited from the community through newspaper advertisements.
The literature investigating mental health and FM have utilized a number of
sampling strategies including convenience sampling from primary and tertiary clinic
settings as well as representative community samples, e.g., random digit dialing, mass
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mailings, advertisement in newspapers, etc. or a combination of both. The role of help­
seeking behaviors in patients and non-patients with FM on mental health functioning has
also been investigated. In terms of data collection, researchers tend to use structured
interviews or paper and pencil self-report inventories or a combination of the two.
Studies investigating differences on levels of mental health functioning in individuals
with FM tend to compare results to healthy controls and/or patients/nonpatients with of
other chronic pain conditions, such as osteoarthritis (OA) and rheumatoid arthritis (RA).
Significant differences between these diseases and FM on a variety of mental health
variables typically obtained through self-report inventories will be examined in the
current paper. Prevalence rates of comorbid conditions of patients and individuals with
FM will be discussed. The prevalence rates of comorbid posttraumatic stress disorder
(PTSD) and FM will also be explored.
Research shows FM patients are at risk for experiencing higher levels of anxiety
and depression than healthy control groups (Malt et al., 2002; Sayar et ah, 2004). When
compared to other chronic pain groups (e.g., RA groups), FM patients tend to experience
greater anxiety, but not depression (Sayar et al., 2004). It is important to note; however,
that differences found on dependent variables (e.g., anxiety and depression) may be
accounted for by variations in the experience of other independent variables, e.g., fatigue
and pain severity. Research has shown that FM patients tend to rate their pain as more
severe than other chronic pain sufferers (Sayar et al., 2004). Therefore, variables such as
fatigue and pain severity can influence levels of depression and anxiety experienced in
FM patients; however, studies have found inconsistent results. The role of fatigue and
pain severity in depression and anxiety as well as other psychiatric disorders in FM is
7
perplexing. The experience of pain and psychiatric disorders appears bi-directional with
each influencing the other. Researchers have yet to determine whether psychiatric
symptoms lead to the development of FM. Some have argued that psychiatric symptoms
cause FM because FM patients generally show higher levels of psychopathology in
comparison to other groups with debilitating illnesses, such as cancer and human
immunodeficiency virus infection (HIV) (Cohen et al, 2002). However, to say FM is a
mere expression of psychiatric disorders is likely too simplistic (Van Houdenhove &
Egle, 2004).
Another possible influence in observed levels of psychiatric disorders in FM is
treatment-seeking. Studies have shown FM patients report increased levels of
neuroticism, anxiety, and depression than FM nonpatients (Aaron et al., 1996; Kersh et
al., 2001; White et al., 2002). However, once the influences of fatigue and pain severity
are controlled, differences observed between FM patients and FM nonpatients often
become non-significant (Aaron et al, 1996). When compared to other pain groups from
an adult representative community sample, individuals with FM report increased levels of
depression, anxiety, and emotional irritability (White et al., 2002). Thus, those affected
by FM tend to experience greater emotional distress than healthy controls and other
chronic pain groups. The influence of treatment-seeking on observed levels of anxiety
and depression is an important consideration when examining studies utilizing
convenience-sampling strategies. Those who seek out treatment from a physician for
symptoms related to FM tend to be more depressed and anxious than those with FM who
do not seek out help. Levels of fatigue and pain severity also appear to influence levels
of anxiety and depression, but findings have been inconsistent.
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In terms of assessing overall prevalence rates of psychiatric disorders in FM,
studies have advanced and become more specific as seen in studies utilizing self-report
inventories. For example, earlier studies examined emotional distress on a more global
level (e.g., levels of anxiety and depression), whereas, more recent studies have
investigated prevalence rates for specific psychiatric disorders. Furthermore, more recent
studies have examined potential differences between current versus lifetime
manifestations of psychiatric disorders as well as the potential differences between FM
patients and FM nonpatients. Additionally, procedures, methodologies, and strategies for
data collection have become increasingly more sophisticated.
Studies using tertiary samples found major depression ranging from 23% (Epstein
et ah, 1999) to 80% (Martinez et ah, 1995) in FM patients. Prevalence rates for lifetime
experiences with major depression in a FM patients range from 20% (Kirmayer et ah,
1988) to 69% (Epstein et ah, 1999). Prevalence rates for current anxiety disorders range
from 27% (Epstein et ah, 1999) to 63.8% (Martinez et al., 1995) in FM patients.
Concerning specific anxiety disorders, lifetime prevalence rates for PTSD ranges from
0% (Aaron et ah, 1996; Epstein et al., 1999; Kirmayer et ah, 1988) to 23.1% (Arnold et
ah, 2006) in FM patients.
Of the seven articles examining psychiatric comorbidity in FM, three observed
higher levels of PTSD or PTSD-like symptoms in patients with FM. Arnold et al. (2006)
found that when compared to RA patients, 23.1% of FM patients versus 5% of RA
patients met criteria for PTSD. Another study found 7.8% of FM patients meeting
criteria for PTSD, but upwards to 41% of FM patients manifested PTSD-like symptoms
(Thieme et al., 2004). In a study using a representative community sample, 14% of
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individuals with FM met criteria for PTSD in their lifetime (Raphael et ah, 2006). While
there is only a modest relationship between PTSD and FM, there is growing literature
that suggests traumatic experiences contribute to the development of FM (Ablin et al.,
2008; Amir et ah, 1997; Amital et al., 2006; Cohen et al., 2002). Furthermore,
researchers have suggested that there is little distinction between a diagnosis of FM and
PTSD because there is so much overlap between the two in terms of symptomatology and
degree of comorbidity with each other (Ablin et al., 2008). Given such claims it is
helpful to further securitize the potential role of PTSD in FM.
FM and PTSD
In one of the earliest accounts investigating PTSD and FM, Amir et al. (1997)
compared PTSD patients with control subjects from a hospital in Israel. The PTSD group
reported the following types of traumas: combat reactions, motor vehicle accidents, work
accidents, and civilian terrorist incidents. Results revealed that six of the thirty patients
were diagnosed with FM. The PTSD group also had increased tenderness, and poorer
quality of life as well as more physical impairment than the control group. The PTSD
group reported experiencing more frequent and severe symptoms, including stiffness,
fatigue, sleep disturbance, headache, paresthesias, and subjective joint swelling.
Moreover, patients with PTSD and FM experienced great pain, fatigue, somatization, and
obsessions as well as a lower quality of life than patients with PTSD and not FM. The
study concluded that there is a great deal of variability in the presentation of FM with
many patients vulnerable to other disorders including PTSD. Additionally, the authors
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concluded the etiology of FM appears attributable to psychological factors (Amir et al,
1997).
In another study exploring the association between FM and PTSD, Cohen et al
(2002) found that upwards of 57% of their sample with FM met criteria for PTSD.
Types of trauma identified by patients included sudden unexpected death of close friend
or relative; involvement in serious motor vehicle accident; witnessing someone being
seriously injured; work accident; military/combat; holocaust survivor syndrome; family
violence; natural disaster; being held captive, tortured or kidnapped; sexual assault; being
diagnosed with a threatening illness (not FM) or one’s child being diagnosed with a life-
threatening illness; and other trauma. Among patients with FM, the most prevalent form
of trauma experienced was sudden, unexpected death of a close friend or relative (35% of
patients with FM). In addition, subjects with FM and PTSD showed decreased levels of
employment, physical functioning, and higher levels of depression and anxiety when
compared to FM patients without PTSD. The authors conclude that there is a high degree
of overlap between FM and PTSD and suggest that they may share similar
pathophysiologic underpinnings.
Amital et al (2006) investigated the comorbidity of PTSD and FM in men with
combat related trauma. The sample consisted of 124 males recruited from a medical
center in Israel. Fifty-five men were diagnosed with PTSD and 20 were diagnosed with
major depressive disorder (MDD) according to the DSM-IV. Forty-nine of the men were
found to be physically healthy. The study found that 49% of the PTSD patients met
ACR criteria for FM. Furthermore, the mean number of tender points reported in the
PTSD group was significantly higher than the other groups. The study also showed that
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PTSD and FM participants displayed poorer levels in sleep quality and quality of life.
Interestingly, the MDD group did not manifest symptoms of FM, where the converse has
been observed in a number of other studies. The authors conclude that trauma may lead
to the development of FM.
Using the Clinician Administered PTSD Scale (CAPS), Ablin et al (2008)
analyzed levels of PTSD in patients with FM. The study sample comprised of 77 patients
(40 women & 37 men) from a hospital in Israel. Forty-one percent of male participants
with FM met criteria for PTSD. Furthermore, FM patients with PTSD reported lower
levels of physical functioning and employment status. The study did not report levels of
PTSD for female participants with FM. The authors concluded that there is a high degree
of overlap between symptoms of PTSD and FM due to the increased frequency of FM
among PTSD patients. The study also highlighted supporting data from physiological
research (e.g., low urinary cortisol levels indicative of hypothalamic-pituitary-adrenal
adaption to chronic stress are similar in FM and PTSD patients).
In sum, the overlap of FM with PTSD found in studies with Israeli patients ranges
from 20% to 57% (Ablin et al., 2008; Amir et al., 1997; Amital et al., 2006; Cohen et al.,
2002). These patients with FM and PTSD tend to experience poorer sleep, quality of life,
greater tenderness, physical impairment, and lower levels of employment in comparison
to non-FM PTSD patients. However, it is important to note that all studies used
convenience sampling strategies, which likely biased results as seen in studies previously
discussed. Moreover, levels of PTSD and PTSD-like symptoms have been lower in
studies with American samples, ranging from 0% (Aaron et al., 1996; Epstein et al.,
1999; Kirmayer et al., 1988) to 23.1% (Arnold et al., 2006). The differences in rates of
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PTSD in FM patients found between studies completed in the US versus Israel are likely
due to contextual factors. People in Israel are more likely to face ongoing terrorism as
opposed to isolated attacks found in the US (Hobfoll, 2007; cited in Lambert, 2007). For
example, studies from Israel report civilian terrorism, holocaust survivor syndrome, being
held captive, tortured, kidnapped, and combat reactions, which are not found in civilian
studies completed in the US. Furthermore, when compared to studies completed in the
US, studies completed in Israel include greater numbers of male patients with FM. It
may be that males exaggerate symptoms of FM because it is culturally acceptable express
physical pain as opposed to emotional pain (Cohen et ah, 2002).
FM and Victimization
As previously mentioned, the research community has not reached a consensus
regarding the etiology of FM and there is currently no cure for the condition. However, a
potential contributing factor cited throughout the medical and psychological literature is
the relationship between physical and sexual abuse and FM. The prevalence rates of
physical abuse reported by patients with FM range from 18% to 47.2%, and from 9.5% to
66.7% for sexual abuse (Boisset-Pioro et ah, 1995; Boyd & Katsaros, 2006; Goldberg et
ah, 1999; Imbierowicz & Egle, 2002; Rubin, 2005; Taylor et ah, 1995; Van Houdenhove
et al, 2001; Walker et ah, 1997). These relationships have led some researchers to
suggest that abuse plays a prominent role in the development of FM (Aaron et ah, 1997;
Clauw & Williams, 2002; Van Houdenhove, 2003).
Alternatively, researchers have argued that the high prevalence of abuse histories
observed in patients with FM maybe largely due to the arbitrary and unstructured nature
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of convenience sampling procedures, i.e., recruiting patients from tertiary care clinics or
primary care providers as opposed to samples drawn from the communities (Ciccone et
ah, 2005; Thieme et ah, 2004; Walker et al., 1997; White et ah, 2002). That is, patients
with FM tend to report higher levels of physical and sexual abuse histories than those
with FM who do not seek out treatment (Aaron et al., 1997; Alexander et al., 1998;
Ciccone et al., 2005). Thus, the relationship and role of abuse experiences in patients
diagnosed with FM remains elusive. Additionally, there is little understanding of the
processes by which abuse affects some patients with FM but not others.
FM and Victimization - Tertiary Samples
In one of the earliest known studies exploring traumatic events, such as child
abuse in patients with FM, Boisset-Pioro et al. (1995) compared the frequency of sexual
and physical abuse in female FM patients to patient controls from a private rheumatology
clinic and a rheumatology clinic at a hospital in Canada. The study found that FM
patients reported more instances of childhood and lifetime (e.g., childhood, adolescences,
and adulthood) sexual abuse, as well as physical abuse, in comparison to the control
group. In addition, the study found that FM patients were more likely to have experienced
both sexual and physical abuse when compared to the control group.
In another early study investigating the prevalence of sexual abuse in women with
FM, Taylor et al. (1995) compared the prevalence of sexual abuse in women diagnosed
with FM and healthy female controls. Patients were recruited from a rheumatology
clinic. The control group comprised of female hospital employees, friends of outpatients,
and service workers. Sexual abuse was defined as the occurrence of contact (e.g.,
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unwanted touching of one’s sexual parts) and noncontact forms of sexual abuse (e.g.,
threatened and unwanted sexual advances) occurring in childhood, adolescences, and
adulthood. Despite 65% of the FM group reporting sexual abuse, the study did not
observe differences between the FM group and control group in terms of prevalence and
type of abuse experienced. One of the study’s interpretations of results included the
tendency of women reporting more symptoms on questionnaires in comparison to men.
However, Walker et al. (1997) have argued that the discrepancies in results between the
Boisset-Pioro et al (1995) and Taylor et al. study may be due to study limitations inherent
in the Taylor et al. study, which include convenience sampling (e.g., the control group
comprised of hospital employees, friends of outpatients, etc.) and its narrow investigation
of the effects of sexual abuse only as opposed to investigating other potential
psychosocial factors, such as emotional abuse, neglect, parental loss, etc. Regardless of
the study’s potential limitations, it found that women with FM who experienced sexual
abuse during their lifetime reported more symptoms (e.g., poorer general health, less
energy, and a decrease in social and recreational activities) in comparison to non-abused
women with FM. Thus, it appears that women with a history of sexual abuse and FM
experience more problematic symptoms in comparison to patients with FM who do not
report a history of sexual abuse.
In a subsequent study investigating victimization in FM patients, Walker et al.
(1997) compared FM patients to patients with rheumatoid arthritis (RA). Study results
suggested that patients with FM reported higher rates of total victimization (e.g.,
emotional abuse, physical abuse, sexual abuse, and emotional neglect) in both adult and
childhood in comparison to the RA group. Therefore, Walker et al.’s study appears to
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expand on previous studies that found high levels of physical and/or sexual abuse
experiences in women with FM by including variables such as emotional abuse and
emotional neglect, which suggests that there may be other forms of abuse associated with
FM that have not been investigated. In addition, the study found that the FM group had
higher levels of repeated forms of abuse (physical assault and rape) occurring in both
childhood and adulthood with physical assault experienced in adulthood showing a strong
relationship with FM.
Goldberg, Pachas, and Keith (1999) examined the relationships between traumatic
events, including sexual and physical abuse along with several other potential factors,
such as death of a friend, separation or divorce, childhood illness, etc. by comparing three
chronic pain conditions: facial pain, myofascial pain, and FM as well as a mixed group
with other pain conditions. The study observed higher percentages of physical and sexual
abuse in the FM group in comparison to the other pain groups. In addition, the FM group
reported a significantly higher percentage of verbal abuse, major family upheaval
experienced during childhood (e.g., separation/divorce), and childhood illness. The FM
group also had higher incidences of having an alcoholic parent and physical abuse;
alcoholic parent and sexual abuse; alcoholic parent and verbal abuse than the three other
pain conditions. Therefore, as suggested in the Walker et al (1997) study, which found
that FM patients experienced increased levels of emotional abuse and emotional neglect
as well as physical and sexual abuse, Goldberg, Pachas, and Keith found that patients
with FM experience a multitude of traumatic events (e.g., childhood illness, having an
alcoholic parent, separation/divorce) in comparison to other chronic pain conditions.
Therefore, it is important for future studies to explore abuse more broadly in addition to
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examining the effects of sexual and physical abuse potentially experienced in childhood.
Having a better understanding of the effects of multiple forms of abuse across time as
well as the cumulative effects of experiencing multiple forms of trauma may provide a
clearer and more comprehensive picture of issues affecting patients with FM.
In another study investigating the prevalence and characteristics of victimization
(e.g., emotional, physical, and sexual abuse) in functional somatic syndromes, which
included patients with FM and Chronic Fatigue Syndrome (CFS), Van Houdenhove et al.
(2001) found that the overall prevalence rate of victimization was significantly higher in
a FM/CFS group than a multiple sclerosis (MS) or rheumatoid arthritis (RA) group, as
well as to a healthy control group. The FM/CFS group experienced significantly more
lifelong victimization experiences as opposed to only experiencing victimization in
childhood or adulthood in comparison to the other groups. In addition, in contrast to the
RA/MS group and healthy control group, the FM/CFS group reported higher rates of
emotional neglect and emotional abuse, which lends support to results found by Walker
et al. (1997), which found FM patients reporting higher levels of emotional neglect and
emotional abuse, suggesting that victimization experiences tend to be broad and global,
not one particular form of abuse contributing to the etiology of FM, such as sexual abuse
only. Furthenuore, the FM/CFS group reported more incidences of physical abuse in
comparison to the healthy control group.
A unique contribution of the Van Houdenhove et al (2001) study is that it further
explored victimization experiences in FM by investigating whether the victimizer was
from one’s family of origin (e.g., parents, siblings), other family members (e.g., partner,
grandparents), and nonfamily members (e.g., school-teachers). The CFS/FM group
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reported greater emotional neglect, emotional abuse, and physical abuse than the RA/MS
and healthy control group. Furthermore, the CFS/FM patients report more emotional
abuse by other family members when compared to the RA/MS and healthy control
groups. Lastly, the CFS/FM group reported higher levels of emotional neglect and
physical abuse from nonfamily members compared with healthy control subjects. Van
Houdenhove et al. study points to the need for future investigations to examine multiple
forms of victimization beyond sexual and physical abuse only. Furthermore, the study
provides a deeper understanding of victimization experiences in FM/CFS patients by
including contextual factors that may occur across time. For example, the FM/CFS group
reported more lifelong victimization perpetrated by the family of origin and by partner.
Therefore, many FM/CFS patients experience a greater level of abuse in their childhoods
perpetrated by their families that carries into their adult lives that is being perpetrated by
their partners.
Imbierowicz and Egle (2003) examined childhood adversities in patients with
FM, somatoform pain disorder (SPD), and a control group with medically explained
chronic pain in Germany. The study chose to compare levels of childhood adversities in
FM with a persistent somatoform pain disorder group because the two disorders share
common risk factors in the etiology of the conditions, e.g., childhood victimization.
Furthermore, the study cites a number of other investigations that suggest that FM or a
subgroup of patients affected by FM also manifest SPD. The FM group reported the
worst relationship with their parents when compared to the control group, as evident by
poorer emotional relationship with the mother, father, and with both parents as well as a
lower sense of security in the family in comparison to the control group and SPD group.
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FM patients also reported greater difficulties expressing their opinions to their parents
when their opinions differed. When compared to the control group, the study found the
FM group experienced physical violence in the family seven fold in comparison to the
control group. Higher levels of sexual abuse, physical maltreatment in childhood, and a
lack of physical care or affection, as well as separation/divorce of parents were also
reported in the FM group in comparison to the control group. Therefore, Imbierowicz and
Egle further confirm that victimization experiences, e.g., sexual or physical abuse, as well
as other childhood adversities are reported with great frequency in FM patients.
In sum, all five studies that investigated physical abuse reported higher prevalence
rates in patients with FM in comparison to healthy controls and/or other chronic pain
groups. In all, the prevalence rates of physical abuse reported by patients with FM range
from 18% to 47.2%. Thus, when compared to health controls and/or other chronic pain
groups, patients with FM tend to report higher levels of physical abuse.
In terms of sexual abuse, when compared to a healthy control group and/or
another chronic pain group, four out of six studies observed higher prevalence rates of
sexual abuse in patients with FM and one study noted that those who reported sexual
abuse manifested more symptoms related to FM than those who did not report sexual
abuse. Overall, the prevalence rate of sexual abuse observed in patients with FM ranged
from 9.5% to 66.7% with a mean of 44.01%. As this wide range suggests, studies
investigating sexual abuse have observed discrepant findings. These studies may be due
to the lack of consistency of methodologies used for attaining victimization histories, e.g.,
interview format versus paper and pencil questionnaire. In addition, some of the
questionnaires chosen may have lacked the specificity or sensitivity needed to assess
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victimization adequately (Walker et al. 1997). Additionally, when compared to studies
carried out in the US, studies completed in Europe (e.g., Germany and Belgium) reported
lower levels of sexual abuse overall. The range of sexual abuse reported by United States
samples of FM patients narrows to 47.06% to 66.7%. Cultural and societal influences
affecting the way a country defines abuse may account for discrepant findings (Schwartz-
Kenney & McCauley, 2009).
Another argument that has been discussed in the literature is the built-in bias
found in convenience sampling. For example, despite observing 65% of the FM patient
group endorsing sexual abuse, Taylor et al. (1995) did not observe a significant statistical
difference between the FM group and control group, which comprised of female hospital
employees, friends of outpatients, and service workers. The high prevalence of sexual
abuse observed in the control group was much higher than sexual abuse rates found in the
general female population, which is 15%-25% (Leserman, 2005). These inconsistencies
do not suggest that results found in the Taylor et al. study are incorrect; however, the
results point to limitations in convenience sampling (Walker et al., 1997).
Furthermore, it can be assumed that FM patients seeking out treatment are
experiencing greater emotional and physical distress than individuals diagnosed with FM
who are out in the community with manageable FM symptoms or are experiencing
symptoms not severe enough to warrant a doctor visit. Therefore, samples drawn from
tertiary clinics or convenience samples, report higher levels of distress including physical
and sexual abuse as well as other victimizations experiences than individuals out in the
community diagnosed with FM because they are in more physical and emotional distress.
As a result, data obtained from convenience samples may distort the role of victimization
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experiences in FM because individuals out in the community with FM who do not seek
out care for their symptoms are not being adequately assessed.
FM and Victimization - Community Samples
In one of the first studies investigating the role of treatment seeking versus non­
treatment seeking in FM, Alexander et al. (1998) examined the prevalence of sexual and
physical abuse by comparing three groups: FM patients, FM nonpatients, and healthy
controls. The FM nonpatient group comprised of women who responded to newspaper
advertisements for volunteers with musculoskeletal pain who had not obtained medical
treatment for their symptoms in the past 10 years. All volunteers were evaluated by a
rheumatologist; those who met ACR criteria for FM were included in the study. Results
showed that 57% of the FM patients reported experiencing one or more episodes of
sexual and/or physical abuse with a majority of participants reporting only childhood
sexual abuse. In addition, FM patients who identified histories of abuse also reported
experiencing higher levels of pain, fatigue, functional disability, and stress. However,
when FM nonpatients were compared with healthy controls, there was not a significant
difference with regard to histories of sexual/physical abuse. Therefore, the high
prevalence of sexual and/or physical abuse found in patients with FM from tertiary
clinics may be a unique characteristic of those who seek FM treatment versus those that
do not.
Aaron et al. (1997) further investigated whether other forms of victimizations
experiences, such as emotional trauma (e.g., family member’s death or severe health
problems, marital stress, etc.) in addition to physical trauma precipitated health care
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seeking in FM patients. The study did not find perceived physical trauma as a predictor
of treatment seeking for FM; however, those who experienced emotional trauma were
more likely to seek out care from an outpatient health care clinic for symptoms related to
FM. The study suggested that experiencing emotionally stressful events may have
contributed to the patient’s perceived uncontrollability of symptoms, which may have
been a motivating factor to seek out care. FM patients who reported emotional trauma
reported traumatic events that were out of their control, which may have influenced their
perception of their physical symptoms as uncontrollable. Thus, sexual and physical
abuse in childhood does not appear to be solely responsible for the development of FM.
Other victimization experiences such as emotional trauma also appear to be playing a
contributing role in FM.
Ciccone et al. (2005) compared victimization experiences in female participants
with FM to participants from a control group without FM from a representative
community sample. Ciccone et al. argued that high prevalence rates of sexual and
physical abuse histories among patients with FM reported by Boisset-Pioro et al. (1995);
Goldberg et al (1999); Walker et al. (1997); and Imbierwiez et al. (2003) may be biased
because of “treatment seeking behavior and psychopathology on abuse reporting” rather
than in the etiology of FM (p. 378). Results showed that the prevalence of childhood
sexual and physical abuse in the FM group and the control were not significantly
different on any abuse category except for rape. The study did not identify whether rape
experiences reported occurred in childhood or adulthood. Women diagnosed with FM
were more likely to report rape than those without an FM diagnoses. Therefore,
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treatment-seeking behavior may be playing a role in the high prevalence of physical and
sexual abuse observed in other studies.
However, in a population-like study investigating over ten thousand participants
from a conservative religious community, Haviland et al. (2009, In print) broadly
examined whether there is a link between traumatic and other major life stressors and
FM. Participants included in the study self-reported whether they have been given a FM
diagnosis by a physician. No follow-up physical exam was provided by a rheumatologist
to confirm FM diagnosis. Traumatic experiences included life threatening events (e.g.,
war, bad accident, natural disaster, witnessing someone seriously injured or killed),
emotional abuse/neglect (e.g., mother or father being insulting, swearing at, or ignored).
physical assault/abuse (e.g., actual and threatened assault in one’s lifetime and
experiencing being pushed, slapped, kicked, bit, etc. by mother or father) and sexual
assault/abuse (actual and threatened sexual abuse in one’ lifetime). Life stressors referred
to serious illness, abortion, miscarriage, divorce/separation, homelessness, and death of a
child. Nearly five percent of the sample identified having a FM diagnosis with 4.8% of
the sample being women and 1.3% of the sample being men. Results found that sexual
assault/abuse and physical assault/abuse were the only traumatic experiences associated
with a FM diagnosis. Life-threatening trauma, emotional abuse/neglect, and major life
stress were not found statistically significant. An unanswered question is whether levels
of victimizations experienced were influenced by treatment seeking. It is conceivable
that those who sought out treatment in the last year for symptoms related to FM
experienced higher levels of victimization experiences than FM nonpatients. The
Haviland et al. study confirms the association between physical and sexual
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assault/abusive experiences in FM, but did not find other forms victimization experiences
as found in other studies (Aaron et ah, 1997; Goldberg, Pachas, & Keith, 1999;
Imbierowicz & Egle, 2003; Van Houdenhove et ah, 2001; Walker et ah, 1997).
Research is beginning to expand its focus by investigating other potential
victimization experiences, such as childhood illness, separations or divorce, death of a
friend/family, family history of alcoholism or drug dependence (Goldberg, Pachas, &
Kieth, 1999), emotional neglect, sexual harassment (Van Houdenhove et ah, 2001;
Walker et ah, 1997), poor relationship with family, low sense of security in family, lack
of physical care (Imbierowicz & Egle, 2003), marital distress, and severe health problems
(Aaron et ah, 1997). These experiences are important to investigate because they provide
a greater context of victimization experiences in FM across time (e.g., childhood,
adolescences, adulthood). However, results have been inconsistent and in some cases
have been unfounded. Therefore, further clarification is needed, especially, in studies
using representative community samples.
Allostatic Load and a Biopsychosocial Model of Stress and FM
A number of theories and models have been developed to help explain the
phenomenon of stress and its effects on the body, e.g., Claude Bernard’s (1878) work on
the consequences of stress, Walter Cannon’s (1929) conceptualization of “homeostasis”
and “flight or fight,” and the General Adaptation Syndrome (Selye, 1936; cited in
Greenberg, Carr, & Summers, 2002). Theories and models have also included the way
one appraises or perceives stress and its impact on health (Lazarus & Folkman, 1985).
Furthennore, notions such as control and helplessness, avoidant and approach coping
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styles, and emotional intelligence have been found to influence one’s perception of stress,
including how one perceives pain, the salient component of FM (Hamilton, Karlson, &
Catley, 2007). As such, many efforts have been made to explain the experience of stress;
however, few have clarified the complex nature of adaptation to stress.
A recent theory by McEwen (1998) may shed light on the role of abuse and/or
trauma experiences as well as their potential cumulative, detrimental effects on health in
individuals diagnosed with FM. McEwen (1998) has proposed that our physiologic
systems, e.g., hypothalamic-pituitary-adrenal (HPA) axis, cardiovascular, metabolic, and
immune systems help protect the body from stress; however, over time, the long term
effects of the body’s reaction to chronic stress can also damage the body. McEwen refers
to this phenomenon as allostatic load, “which is the wear and tear that results from
chronic overactivity or underactivity of allostatic systems” (p. 171). That is, a person
may experience physical symptoms as a result of persistent, recurrent stressful or
traumatic events. Consequently, the body may lose its ability to regulate itself
physiologically, leading to long term chronic conditions, such as FM (Health Letter
Associates, 2008; Friedman & McEwen, 2004).
Logan and Barksdale (2008) provide a wonderful rubber band analogy to help
explain four potential response patterns to stress that lead to allostatic load. In their
example, Logan and Barksdale use a standard rubber band to represent our
physiologic/allostatic systems, e.g., hypothalamic-pituitary-adrenal (HPA) axis,
cardiovascular, metabolic, and immune systems. Like most rubber bands, when they are
stretched, then released, they return to their original size. However, if the rubber band is
stretched repeatedly, it will not return to its original size because it has lost its elasticity.
25
This represents McEwen’s first response pattern where the individual experiences
repeated stress/trauma, which results in allostatic load. Logan and Barksdale’s second
response pattern is represented by a rubber band that is stretched consistently with
increasing strength. Over time, the rubber band will lose elasticity or be stretched to a
point it will break. The second analogy speaks to a person unable to habituate or become
accustomed to prolonged exposure to stress or trauma. In Logan and Barksdale’s third
example, the rubber band is stretched too much at once causing it to break. Here, the
rubber band represents the body’s physiologic systems remaining at a high level of
activation that is unable to turn off its allostatic response, which prevents the body from
recovering. Logan and Barksdale’s last example depicts a rubber band with deficits that
makes it thinner and weaker in areas, which make it susceptible to break even when it is
stretched with a small amount of tension. In this case, the body’s allostatic systems are
inadequate and unable to meet demands required when faced with stress or trauma,
resulting in systems that overcompensate and increase allostatic load. These four
possible stress response patterns reflect overactivity or underactivity of our physiologic
systems, which can result in allostatic load, increasing one’s chances of developing a
chronic illness.
McEwen (2008) current model suggests on a physiologic level, allostatic systems
become overactive in FM patients due to an inadequate hormonal stress response or HPA
axis. Lower levels of cortisol and catecholamines (hormones) are unable to regulate or
contain inflammatory cytokines, which has shown to be a manifestation of FM (McEwen,
2008; McEwen, 1999). That is, the body’s allostatic systems are likely inadequate in
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individuals with FM, resulting to systems to overcompensate, consequently, increasing
one’s allostatic load (McEwen, 1999).
To help explain potential factors that lead to an inadequate allostatic system in
FM, Van Houdenhove & Egle (2004) present a persuasive conceptualization of stress and
FM utilizing a biopsychosocial model. Their model of stress and FM is a multi-layered,
bi-directional interaction between predisposing (genetic, environmental, personality),
precipitating (e.g., painful injury, infection) and perpetuating factors (comorbid
depression and anxiety). Citing research from both animal and human research, Van
Houdenhove & Egle point to traumatic stress, especially, when experienced early in
childhood can alter one’s allostatic system, leading to increased susceptibility to stress
and disorders associated with stress, including FM. Types of trauma that may disrupt the
allostatic system include emotional, physical, sexual abuse during childhood, maternal
stress during early infancy as well as the interaction of physical stresses to the body, such
as infections or early inflammation processes.
Although Van Houdenhove & Egle (2004) do not use the term “allostatic”
systems in their model, their perspective shares elements of the concept. They identify
the body’s achievement of analgesia in response to acute stress and the damaging effects
chronic stress to the body. Furthermore, they highlight the role of pro-cytokines,
neuroinflanimation, and neuroimmune activation in the experience of pain. However, the
main purpose of the article is to provide a conceptualization of factors that lead to the
development and maintenance of FM, which they view as primarily a stress disorder.
Yet, as seen in the studies reviewed in the current paper, victimization experiences are
not found in all patients and individuals with FM. Van Houdenhove & Egle address
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these inconsistencies by discussing the variable impact of victimization experiences in
the etiology of FM, such as the type of trauma, severity of trauma, frequency of trauma,
etc. and the role of protective factors. Additionally, the authors believe that subtle
emotional stressors, such as chronic parental disharmony or parental depression as well
as protective factors are not often assessed in research investigating victimization
experiences in FM.
To summarize the development and maintenance of FM according to Van
Houdenhove & Egle (2004) biopsychosocial model, people with FM are likely sensitive
to stress based on their genetics, making them susceptibility to adverse developmental
factors (e.g., insecure attachment) and environmental factors (victimization experiences).
These susceptibilities and experiences further increase their sensitivity to stress.
Personality factors (e.g., negativism), poor emotional regulation (e.g., alexithymia, low
self-esteem, high anxiety/depression), and poor coping skills (e.g., immature defense
mechanisms) often lead to unhealthy behaviors (e.g., lack of exercise, poor nutrition,
drugs and alcohol), poor relationships, and decreased role functioning.
Other psychosocial factors (e.g., care giving, conflict within the family, job
dissatisfaction) as well as physical factors (e.g., poor sleep, painful injury, and infection)
can also contribute to the development of FM. The authors allude to an allostatic load
phenomenon where the body eventually cannot respond adequately to multiple stressors
in addition to new stressors, which leads to further deleterious consequences to the body,
including the hypothalamic-pituitary-adrenal (HPA) axis, cardiovascular, metabolic, and
immune systems (Van Houdenhove & Egle, 2004).
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Stress-related factors that appear maintain FM identified by Van Houdenhove &
Egle (2004) include “the burden of continuing pain, ongoing anxiety, depression,
irritability, worrying, catastrophic thinking, somatic hypervigilance, non-restorative sleep
and inadequate health-care seeking behavior” (p. 271). Other factors that may maintain
symptoms of FM include physical inactivity, social withdrawal, secondary gain,
secondary gain, and disputes with physicians (Van Houdenhove & Egle, 2004).
Discussion
In conclusion, the relationship of sexual and physical abuse and other
victimization experiences in individuals with FM has not been consistent in the empirical
literature. Researchers are beginning to note potential limitations of investigations using
convenience sampling. One could argue that differences may lie between patients and
non-patients on victimization variables, specifically histories of sexual/physical abuse
and patients with FM, i.e., patients with FM report higher incidents of sexual/physical
abuse in general. However, it is likely too early to make such a claim given the dearth of
research in this area. In addition to patient selection procedures, other potential
influences that may explain discrepancy in results include the use of self-report
questionnaires versus structured interview formats, the influence of varying definitions of
victimization, age and gender groups, as well as the possible influence of psychotherapy
experiences in disclosure (Van Houdenhove et al., 2001). People who have been in
psychotherapy may be more willing to disclose personal information about themselves
than those who have not participated in psychotherapy. It also could be that various
victimization experiences have differential impact in the etiology of FM, as might various
protective factors (e.g., spousal support, active coping styles, etc.).
Statistical sophistication (e.g., choosing whether or not to control the influence of
certain variables, such as demographics and pain severity) and type of statistical
calculation completed (e.g., Pearson’s chi square versus multivariable logistic regression)
can also influence results. Authors should provide greater transparency by disclosing
their thought process/philosophy regarding whether to control the influence of certain
variables and choice of statistical calculation so that readers can make a more informed
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decision about the veracity of results. Additionally, with the rise of globalization and use 
of the internet, more is needed in terms of addressing possible cultural influences in light
of results. For example, authors could point out differences and discuss possible
implications between definitions used in the US versus other countries. Furthermore, it is
important for authors to include cultural ramifications when discussing results. For
example, it is mandatory for almost all citizens of Israel to join the military, whereas,
military service in the US is voluntary (Sullivan, 2007). Thus, the nature and quality of
traumatic experiences investigated in studies from Israeli may not be as readily
comparable to civilian studies completed in the US.
Regardless, it is essential for researchers to continue investigating victimization
experiences in FM. Previous research has shown an association between childhood
sexual abuse, medical utilization, and medical problems, such as FM, gastrointestinal,
gynecologic problems, etc. (Lechner, et al. 1993; Newman, et al., 2000). Victimization
experiences have also been shown to increase health risk behaviors, including smoking,
drinking, and drug abuse (Springs & Friedrich, 1992). Additionally, physically/sexually
abused FM patients have also reported greater levels of pain, fatigue, disability as well as
lower levels of self-efficacy than non abused patients (Alexander et al., 1998).
Consequently, victimization experiences can have a wide reaching negative impact on
physical and emotional well-being.
Possible areas for future research include expanding the scope of victimization
experiences, for example, investigating other types of victimization experiences beyond
sexual and physical abuse as potential contributors to the etiology of FM. Assessing
chronicity of victimization experiences, including childhood, adolescent, and adult forms
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of abuse may also provide a richer context of victimization experiences in FM. More
sensitive assessment measures of traumatic experiences, such as assessing chronic
parental disharmony or caregiver depression in FM have also been suggested (Van
Houdenhove & Egle, 2004). Further studies are also needed to explore the
neurobiological basis of mental health, victimization experiences, and FM. Moreover,
studies utilizing representative community samples are needed. Results from future
studies investigating victimization experiences in FM can help develop more sensitive
treatment protocols for health care providers.
A challenging component in the assessment and treatment of FM is secondary
gains, which are external gains including personal attention and service, monetary gains,
disability benefits, and release from unpleasant responsibilities (Shahrokh & Hales,
2003). In no way do all patients with FM present with secondary gains; however, given
the chronic nature of the condition some may be at risk. It is important for care providers
to be aware, assess, and treat secondary gains appropriately. More empirical studies are
needed to identify factors that differentiate FM patients that present with secondary gains
than those who do not (Aaron et ah, 2001).
Because there appears to be a link between FM patients and victimization
experiences, it is essential for psychologist and other qualified care providers to assess
victimization experiences once rapport and trust have been established. Common factors
that can facilitate rapport include empathy, validation, and assurance of the patient’s pain
experience (Rubin, 2005). Additionally, conceptualizing FM as a stress disorder can
decrease defensiveness and possibly open up a discussion about possible contributing
psychosocial factors in the maintenance of FM, such as poor sleep, anxiety/depression,
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alcohol abuse, etc. (Van Houdenhove & Egle, 2004). Teach, identify, and replace
cognitive distortions, such as catastrophizing can also improve overall functioning in FM
patients (Hallberg & Carlsson, 2000). Educating patients about concepts such as
allostatic load in terms of the role of stress, abuse and/or traumatic experiences in FM can
also facilitate coping by fostering understanding to an otherwise uncertain illness state
(Johnson, Zautra, & Davis, 2006). These steps can facilitate effective coping and foster
more adaptive lifestyles, which will in turn, improve quality of life and decrease
symptoms related to FM.
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